CDDDP Official Website, Investigators Profile
  • Professor C. Babalola
  • B.Pharm. (OAU), M.Pharm. (OAU), Ph.D (OAU)
  • A professor of Pharmacokinetics/Pharmaceutical Chemistry and the current dean of the Faculty, is the Co- Principal Investigator of the Centre for Drug Discovery, Development and Production, and the current Dean of the Faculty of Pharmacy, University of Ibadan. Her research interests are drug analysis, pharmacokinetics/pharmacodynamics(PK/PD), biopharmaceutics, clinical trials and pharmacogenetics; with special reference to antimalarial and anti-infective agents.

  • Professor O.A. Itiola
  • B.Pharm. (OAU), M.Pharm. (UL), Ph.D(UL)
  • The Co- Principal Investigator of the Centre for Drug Discovery, Development and Production.He is a professor of pharmaceutics and pharmaceutical technology in the Faculty of Pharmacy. He is the rector of Moshood Abiola Polytechnic, Abeokuta, Nigeria.His research interests include studies on drug formulation and drug delivery systems incorporating mucoadhesive properties of polymer systems and transdermal delivery of drugs.

  • Professor J.O. Moody
  • B.Pharm. (OAU), M.Pharm. (OAU), Ph.D(OAU)
  • Jones Olanrewaju Moody is a Professor of Pharmacognosy in the University of Ibadan, Nigeria. Professor Moody’s expertise is in the area of phytochemistry and drug discovery from nature for the management of malaria, sickle cell disease, and inflammation-based diseases. He has been consultant to the West African Health Organisation (WAHO) for the development of traditional medicine in the West African sub-region since 2009.

  • Professor Grace O. Gbotosho
  • B.Pharm. (OAU), M.Pharm. (OAU), Ph.D(OAU)
  • Professor Grace Olusola Gbotosho specializes in Clinical Pharmacokinetics and Chemoterapy. Her research interest began with focus on the reversal of antimalarial drug resistance by non-antimalarial drugs using standard in vitro drug sensitivity techniques. Her research career has also expanded into the area of molecular pharmacology and molecular epidemiology, Pharmacodynamic and pharmacokinetic studies, HIV/AIDS and tuberculosis as they interact with malaria as prevalence both diseases are on the increase in Nigeria.

  • Dr Michael Odeniyi
  • B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)
  • Michael A. Odeniyi graduated from the University of Ibadan, Ibadan, Nigeria where he obtained his Bachelor of Pharmacy, MSc and PhD degrees. A former Sub-Dean (Undergraduate and postgraduate programmes) of the Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.Dr. M.A. Odeniyi is a recipient of the postdoctoral fellowship to Gifu Pharmaceutical University , Gifu, Japan and also a visiting scientist to Universiti Sains Malaysia (USM).

  • Dr B. Samuel
  • B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)
  • Dr Babatunde Samuel is a Lecturer in Pharmaceutical Chemistry Department, University of Ibadan. His research focus is in Natural Product Research and has many years research experience in phytomedicine development. He holds a US Patent with other senior scientists on a Phytopharmaceutical product for the treatment of sickle cell disease [Niprisan]. The same product was patented in 42 countries.

  • Dr O. A. Adetunji
  • B.Pharm. (UI), M.Pharm. (UI), Ph.D (UI)
  • Oladapo Adetunji is a graduate of the University of Ibadan, Ibadan, Nigeria where he obtained his Bachelor of Pharmacy (B.Pharm), MSc (Pharmaceutics) and PhD degrees. He currently teaches in the department of Pharmaceutics and Industrial Pharmacy, University of Ibadan, Ibadan, Nigeria and is also a co-investigator in the Centre for Drug Discovery, Development and Production (CDDDP) of the University of Ibadan, Nigeria. Prior to now, he has practiced in the Pharma Industry and Community Pharmacy.

  • Professor Joseph Fortunak
  • BS (Purdue, US), Ph.D (Wisconsin, US)
  • Joseph Fortunak is a Professor of Chemistry and Pharmaceutical Sciences at Howard University in Washington, DC. He obtained a Bachelor of Science (B.Sc) in Chemistry from Purdue University and andM.Sc and PhD with highest distinction in Organic chemistry from the University of Wisconsin-Madison. He was a postdoctoral fellow and research professor at Cambridge University, United Kingdom. Joseph Fortunak is an ardent advocate in increasing global access to medicines, especially through pharmaceutical manufacturing in Africa.

  • Pharm. (Mrs.) Olayinka Adejoke Kotila
  • B.Pharm. (UI), M.Pharm. (UI)
  • Pharm. (Mrs.) Olayinka Adejoke Kotila is a lecturer in the department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan. She graduated from the University of Ibadan as a Pharmacist in 1999, obtained her Master of Science (M.Sc) degree in Pharmaceutical Chemistry from the same institution in 2006 and is rounding up Ph.D training in the field of Pharmacogenetics/Pharmacokinetics. She successfully genotyped over five hundred Nigerians (healthy and persons living with HIV) to determine the frequency of N-acetyltransferase II (NAT2) enzyme, making it the largest sample size for any African population genotyped for the enzyme. Pharm. (Mrs.) Kotila has been a recipient of several awards among which are: MacArthur Foundation Grant, Wellcome Trust Bursary Award, Medical Education Partnership Initiative Nigeria (MEPIN) Seed Award, NIH D43 Re-entry Grant Award, Novartis Scholarship Award and TETFUND award.